Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer

Breast Cancer Research and Treatment

Volumn 112, Issue 1, 2008, Pages 41-52

  Ruckhäberle, Eugen ^a   Rody, Achim ^a   Engels, Knut ^a   Gaetje, Regine ^a   Von Minckwitz, Gunter ^a   Schiffmann, Susanne ^a   Grösch, Sabine ^a   Geisslinger, Gerd ^a   Holtrich, Uwe ^a   Karn, Thomas ^a   Kaufmann, Manfred ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Breast cancer; Ceramide; Sphingolipid metabolism; SPHK1

Indexed keywords

CERAMIDE GALACTOSYLTRANSFERASE; DIHYDROCERAMIDE SYNTHASE; ESTROGEN RECEPTOR; GALACTOSYLTRANSFERASE; GANGLIOSIDE GD3; GANGLIOSIDE GD3 SYNTHASE; GLUCOSYLCERAMIDASE; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; SYNTHETASE; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; BREAST CANCER; CARCINOMA CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; MAJOR CLINICAL STUDY; METASTASIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; SURVIVAL;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; LYSOPHOSPHOLIPIDS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; SPHINGOSINE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 52949143502     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9836-9     Document Type: Article

References (36)

1. R Simstein M Burow A Parker C Weldon B Beckman 2003 Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system Exp Biol Med (Maywood) 228 995 1003
2. B Ogretmen YA Hannun 2004 Biologically active sphingolipids in cancer pathogenesis and treatment Nat Rev Cancer 4 604 616
3. Y Lavie H Cao SL Bursten AE Giuliano MC Cabot 1996 Accumulation of glucosylceramides in multidrug-resistant cancer cells J Biol Chem 271 19530 19536
4. YY Liu TY Han AE Giuliano MC Cabot 2001 Ceramide glycosylation potentiates cellular multidrug resistance FASEB J 15 719 730
5. B Ogretmen YA Hannun 2001 Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance Drug Resist Updat 4 368 377
6. JR Van Brocklyn N Young R Roof 2003 Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells Cancer Lett 199 53 60
7. VE Nava JP Hobson S Murthy S Milstien S Spiegel 2002 Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells Exp Cell Res 281 115 127
8. AP Struckhoff R Bittman ME Burow S Clejan S Elliott T Hammond 2004 Novel ceramide analogs as potential chemotherapeutic agents in breast cancer J Pharmacol Exp Ther 309 523 532
9. KJ French JJ Upson SN Keller Y Zhuang JK Yun CD Smith 2006 Antitumor activity of sphingosine kinase inhibitors J Pharmacol Exp Ther 318 596 603
10. O Cuvillier 2007 Sphingosine kinase-1-a potential therapeutic target in cancer Anticancer Drugs 18 105 110
11. O Modlich HB Prisack M Munnes W Audretsch H Bojar 2005 Predictors of primary breast cancers responsiveness to preoperative epirubicin/ cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures J Transl Med 3 32
12. Y Wang JG Klijn Y Zhang AM Sieuwerts MP Look F Yang D Talantov M Timmermans ME Meijer-van Gelder J Yu T Jatkoe EM Berns D Atkins JA Foekens 2005 Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 9460 671 679
13. LD Miller J Smeds J George VB Vega L Vergara A Ploner Y Pawitan P Hall S Klaar ET Liu J Bergh 2005 An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Proc Natl Acad Sci USA 102 38 13550 13555
14. Y Pawitan J Bjohle L Amler AL Borg S Egyhazi P Hall X Han L Holmberg F Huang S Klaar ET Liu L Miller H Nordgren A Ploner K Sandelin PM Shaw J Smeds L Skoog S Wedren J Bergh 2005 Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts Breast Cancer Res 7 6 R953 R964
15. C Sotiriou P Wirapati S Loi A Harris S Fox J Smeds H Nordgren P Farmer V Praz B Haibe-Kains C Desmedt D Larsimont F Cardoso H Peterse D Nuyten M Buyse MJ Van de Vijver J Bergh M Piccart M Delorenzi 2006 Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis J Natl Cancer Inst 98 4 262 272
16. The International Genomics Consortium (IGC). The expO project (Expression Project For Oncology) http://www.intgen.org/
17. Y Gong K Yan F Lin K Anderson C Sotiriou F Andre FA Holmes V Valero D Booser JE Pippen Jr S Vukelja H Gomez J Mejia LJ Barajas KR Hess N Sneige GN Hortobagyi L Pusztai WF Symmans 2007 Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study Lancet Oncol 8 3 203 211
18. JA Foekens D Atkins Y Zhang FC Sweep N Harbeck A Paradiso T Cufer AM Sieuwerts D Talantov PN Span VC Tjan-Heijnen AF Zito K Specht H Hoefler R Golouh F Schittulli M Schmitt LV Beex JG Klijn Y Wang 2006 Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer J Clin Oncol 24 11 1665 1671
19. L Zhi BP Leung AJ Melendez 2006 Sphingosine kinase 1 regulates pro-inflammatory responses triggered by TNFalpha in primary human monocytes J Cell Physiol 208 1 109 115
20. A Olivera N Urtz K Mizugishi Y Yamashita AM Gilfillan Y Furumoto H Gu RL Proia T Baumruker J Rivera 2006 IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses J Biol Chem 281 5 2515 2525
21. TA Taha TD Mullen LM Obeid 2006 A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death Biochim Biophys Acta 1758 2027 2036
22. DA Berry C Cirrincione IC Henderson ML Citron DR Budman LJ Goldstein 2006 Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer JAMA 295 1658 1667
23. JJ van der Hage SJ Mieog M van de Vijver C van de Velde 2007 Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis Breast Cancer Res 9 R70
24. OM Omran HE Saqr AJ Yates 2006 Molecular mechanisms of GD3-induced apoptosis in U-1242 MG glioma cells Neurochem Res 31 1171 1180
25. G Zeng L Gao S Birkle RK Yu 2000 Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production Cancer Res 60 6670 6676
26. D Manka Z Spicer DE Millhorn 2005 Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver, and bone Cancer Res 65 11689 11693
27. F Yang JA Foekens J Yu AM Sieuwerts M Timmermans JG Klijn 2006 Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways Oncogene 25 1413 1419
28. H Liu RE Toman SK Goparaju M Maceyka VE Nava H Sankala 2003 Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis J Biol Chem 278 40330 40336
29. A Huwiler U Zangemeister-Wittke 2007 Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy Crit Rev Oncol Hematol 63 150 159
30. KJ French RS Schrecengost BD Lee Y Zhuang SN Smith JL Eberly 2003 Discovery and evaluation of inhibitors of human sphingosine kinase Cancer Res 63 5962 5969
31. T Kawamori W Osta KR Johnson BJ Pettus J Bielawski T Tanaka 2006 Sphingosine kinase 1 is up-regulated in colon carcinogenesis FASEB J 20 386 388
32. JR Van Brooklyn CA Jackson DK Pearl MS Kotur PJ Snyder TW Prior 2005 Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines J Neuropathol Exp Neurol 64 695 705
33. S Modok HR Mellor R Callaghan 2006 Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer Curr Opin Pharmacol 6 350 354
34. A Pilorget M Demeule S Barakat J Marvaldi J Luis R Beliveau 2007 Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells J Neurochem 100 1203 1210
35. F Döll J Pfeilschifter A Huwiler 2005 The epidermal growth factor stimulates sphingosine kinase-1 expression and activity in the human mammary carcinoma cell line MCF7 Biochim Biophys Acta 1738 72 81
36. M Osada Y Yatomi T Ohmori H Ikeda Y Ozaki 2002 Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist Biochem Biophys Res Commun 299 483 487